 Andrew Bubak
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 20 | 2024 | 331 | 5.420 |
Why?
| | Herpes Zoster | 12 | 2024 | 317 | 3.970 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 212 | 3.300 |
Why?
| | Varicella Zoster Virus Infection | 5 | 2024 | 25 | 2.480 |
Why?
| | Aggression | 6 | 2020 | 195 | 2.130 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 46 | 2.010 |
Why?
| | Serotonin | 6 | 2020 | 319 | 2.000 |
Why?
| | Diptera | 5 | 2020 | 29 | 1.910 |
Why?
| | Astrocytes | 3 | 2020 | 189 | 1.660 |
Why?
| | Arteritis | 2 | 2021 | 24 | 1.320 |
Why?
| | Peptide Fragments | 3 | 2024 | 688 | 1.220 |
Why?
| | Virus Activation | 3 | 2024 | 83 | 1.100 |
Why?
| | Macaca mulatta | 3 | 2024 | 147 | 1.060 |
Why?
| | Virus Diseases | 4 | 2022 | 210 | 1.030 |
Why?
| | Behavior, Animal | 3 | 2019 | 502 | 0.990 |
Why?
| | Stroke | 4 | 2023 | 1073 | 0.980 |
Why?
| | Cytokines | 3 | 2024 | 1994 | 0.870 |
Why?
| | DNA, Viral | 3 | 2024 | 348 | 0.850 |
Why?
| | Substance P | 2 | 2020 | 43 | 0.840 |
Why?
| | Exanthema | 2 | 2022 | 74 | 0.790 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 129 | 0.780 |
Why?
| | Octopamine | 3 | 2016 | 8 | 0.760 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2019 | 84 | 0.740 |
Why?
| | Adventitia | 1 | 2021 | 42 | 0.730 |
Why?
| | Temporal Arteries | 1 | 2021 | 45 | 0.720 |
Why?
| | Giant Cell Arteritis | 1 | 2021 | 47 | 0.720 |
Why?
| | Models, Animal | 2 | 2020 | 367 | 0.720 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 90 | 0.710 |
Why?
| | Antibodies, Viral | 3 | 2024 | 601 | 0.710 |
Why?
| | Antigens, Viral | 1 | 2021 | 174 | 0.700 |
Why?
| | Antiviral Agents | 4 | 2022 | 711 | 0.690 |
Why?
| | Amyloid | 1 | 2021 | 84 | 0.690 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 16 | 0.680 |
Why?
| | Receptors, Serotonin | 1 | 2020 | 33 | 0.670 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.660 |
Why?
| | Vascular Remodeling | 1 | 2021 | 181 | 0.660 |
Why?
| | Meningitis | 1 | 2020 | 80 | 0.620 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 12 | 0.610 |
Why?
| | Dopamine | 3 | 2016 | 285 | 0.610 |
Why?
| | Pseudopodia | 1 | 2018 | 22 | 0.600 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 112 | 0.590 |
Why?
| | Alzheimer Disease | 1 | 2022 | 517 | 0.540 |
Why?
| | Fibroblasts | 1 | 2021 | 937 | 0.530 |
Why?
| | Ants | 1 | 2016 | 27 | 0.520 |
Why?
| | Spinal Cord | 1 | 2018 | 354 | 0.510 |
Why?
| | MPTP Poisoning | 1 | 2015 | 6 | 0.480 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2015 | 73 | 0.470 |
Why?
| | Dopaminergic Neurons | 1 | 2015 | 57 | 0.460 |
Why?
| | Social Perception | 1 | 2015 | 104 | 0.450 |
Why?
| | Agonistic Behavior | 1 | 2013 | 2 | 0.440 |
Why?
| | Sex Characteristics | 1 | 2019 | 722 | 0.430 |
Why?
| | Biogenic Monoamines | 1 | 2013 | 15 | 0.430 |
Why?
| | Hippocampus | 1 | 2018 | 832 | 0.430 |
Why?
| | Varicellovirus | 2 | 2024 | 16 | 0.420 |
Why?
| | Brain Chemistry | 1 | 2013 | 115 | 0.410 |
Why?
| | Animals | 16 | 2024 | 34647 | 0.400 |
Why?
| | 5-Hydroxytryptophan | 3 | 2019 | 20 | 0.370 |
Why?
| | Herpesviridae Infections | 2 | 2024 | 134 | 0.370 |
Why?
| | Cells, Cultured | 6 | 2021 | 4017 | 0.370 |
Why?
| | Acyclovir | 2 | 2020 | 99 | 0.330 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 428 | 0.310 |
Why?
| | Male | 14 | 2024 | 63045 | 0.310 |
Why?
| | Humans | 23 | 2024 | 128499 | 0.290 |
Why?
| | Gene Expression | 3 | 2020 | 1455 | 0.270 |
Why?
| | Host-Pathogen Interactions | 2 | 2020 | 349 | 0.260 |
Why?
| | Chickenpox | 2 | 2024 | 80 | 0.240 |
Why?
| | Trigeminal Ganglion | 1 | 2024 | 25 | 0.230 |
Why?
| | Monkey Diseases | 1 | 2024 | 19 | 0.220 |
Why?
| | Trigeminal Neuralgia | 1 | 2024 | 16 | 0.220 |
Why?
| | Tyramine | 2 | 2013 | 10 | 0.220 |
Why?
| | Herpes Simplex | 1 | 2024 | 93 | 0.220 |
Why?
| | Neuralgia, Postherpetic | 1 | 2024 | 40 | 0.220 |
Why?
| | Herpesvirus 1, Human | 1 | 2024 | 87 | 0.210 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 93 | 0.210 |
Why?
| | Nerve Block | 1 | 2024 | 65 | 0.210 |
Why?
| | Immunoglobulin G | 2 | 2024 | 844 | 0.210 |
Why?
| | Presenilin-1 | 1 | 2022 | 31 | 0.200 |
Why?
| | Inflammation | 3 | 2022 | 2666 | 0.200 |
Why?
| | Microglia | 1 | 2024 | 229 | 0.200 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.200 |
Why?
| | Neuralgia | 1 | 2024 | 119 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.190 |
Why?
| | Neuroblastoma | 1 | 2023 | 153 | 0.190 |
Why?
| | Viral Proteins | 1 | 2024 | 323 | 0.190 |
Why?
| | Tissue Fixation | 1 | 2021 | 34 | 0.190 |
Why?
| | Paraffin Embedding | 1 | 2021 | 29 | 0.190 |
Why?
| | Plasma | 1 | 2023 | 200 | 0.180 |
Why?
| | Formaldehyde | 1 | 2021 | 59 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 70 | 0.180 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 9 | 0.180 |
Why?
| | Olfactory Bulb | 1 | 2022 | 136 | 0.180 |
Why?
| | DNA, Complementary | 1 | 2021 | 267 | 0.180 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 8 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 343 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 67 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 76 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 68 | 0.170 |
Why?
| | Cell Movement | 3 | 2019 | 936 | 0.170 |
Why?
| | Antigens, CD | 2 | 2019 | 482 | 0.170 |
Why?
| | Intracellular Space | 1 | 2020 | 70 | 0.160 |
Why?
| | Protein Aggregates | 1 | 2020 | 67 | 0.160 |
Why?
| | Extracellular Space | 1 | 2020 | 119 | 0.160 |
Why?
| | Tacrolimus | 1 | 2020 | 140 | 0.160 |
Why?
| | Radiosurgery | 1 | 2022 | 319 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 343 | 0.160 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 80 | 0.160 |
Why?
| | Aged | 5 | 2024 | 21976 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 86 | 0.160 |
Why?
| | Tachykinins | 1 | 2019 | 6 | 0.160 |
Why?
| | Receptors, Serotonin, 5-HT2 | 1 | 2019 | 3 | 0.160 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 10 | 0.160 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 9 | 0.160 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 293 | 0.160 |
Why?
| | Female | 8 | 2024 | 68268 | 0.160 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 40 | 0.150 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 9 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 11 | 0.150 |
Why?
| | Neuropeptides | 1 | 2019 | 71 | 0.150 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 92 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 119 | 0.150 |
Why?
| | Cadherins | 1 | 2019 | 188 | 0.150 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 311 | 0.140 |
Why?
| | Risk | 1 | 2020 | 853 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 238 | 0.140 |
Why?
| | MicroRNAs | 1 | 2024 | 674 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 533 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 435 | 0.140 |
Why?
| | Aortic Diseases | 1 | 2018 | 114 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2019 | 190 | 0.140 |
Why?
| | Protein Isoforms | 1 | 2018 | 378 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5281 | 0.130 |
Why?
| | Nesting Behavior | 1 | 2016 | 17 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 518 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 573 | 0.130 |
Why?
| | Touch | 1 | 2016 | 34 | 0.130 |
Why?
| | Neurotransmitter Agents | 1 | 2016 | 78 | 0.130 |
Why?
| | Immunosuppressive Agents | 1 | 2020 | 684 | 0.130 |
Why?
| | Proteomics | 1 | 2022 | 1018 | 0.130 |
Why?
| | Interleukin-6 | 1 | 2019 | 715 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 883 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 901 | 0.120 |
Why?
| | Caudate Nucleus | 1 | 2015 | 20 | 0.120 |
Why?
| | Body Size | 1 | 2015 | 102 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2020 | 2679 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1689 | 0.110 |
Why?
| | Risk Assessment | 1 | 2023 | 3232 | 0.110 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2013 | 42 | 0.110 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2013 | 26 | 0.110 |
Why?
| | Flight, Animal | 1 | 2013 | 23 | 0.110 |
Why?
| | Competitive Behavior | 1 | 2013 | 41 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 842 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 64 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2020 | 3339 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1404 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2516 | 0.100 |
Why?
| | Middle Aged | 3 | 2024 | 30923 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 335 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2024 | 3947 | 0.090 |
Why?
| | Brain | 2 | 2024 | 2624 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 3893 | 0.080 |
Why?
| | Virus Replication | 2 | 2022 | 444 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7057 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2719 | 0.070 |
Why?
| | Mice | 4 | 2024 | 16620 | 0.060 |
Why?
| | Risk Factors | 1 | 2018 | 9737 | 0.060 |
Why?
| | Virus Latency | 1 | 2024 | 78 | 0.060 |
Why?
| | Central Nervous System | 1 | 2024 | 254 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Adrenal Cortex | 1 | 2022 | 27 | 0.050 |
Why?
| | Apoptosis | 2 | 2023 | 2437 | 0.050 |
Why?
| | Adult | 2 | 2024 | 35302 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 49 | 0.050 |
Why?
| | Primary Cell Culture | 1 | 2022 | 157 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 39 | 0.050 |
Why?
| | Cerebral Arteries | 1 | 2021 | 57 | 0.040 |
Why?
| | Interleukins | 1 | 2022 | 241 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 382 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 185 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2023 | 308 | 0.040 |
Why?
| | Claudin-1 | 1 | 2019 | 21 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 108 | 0.040 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 47 | 0.040 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 29 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 228 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 87 | 0.040 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 48 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 226 | 0.040 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 89 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 245 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 222 | 0.030 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 227 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1187 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 469 | 0.030 |
Why?
| | Macrophages | 1 | 2024 | 1464 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 941 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 539 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2069 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2741 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1394 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 855 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2019 | 1045 | 0.030 |
Why?
| | RNA | 1 | 2019 | 881 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 5740 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2345 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9001 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 10487 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 12349 | 0.020 |
Why?
| | Adolescent | 1 | 2024 | 20304 | 0.020 |
Why?
| | Child | 1 | 2024 | 20805 | 0.010 |
Why?
|
|
Bubak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|